Last Updated :2024/12/13
Research activity information
Paper
- Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer.
Ayumu Mitsuyoshi; Masayuki Nagahashi; Haruka Kanaoka; Aoi Oshiro; Yusa Togashi; Akira Hattori; Junko Tsuchida; Tomoko Higuchi; Arisa Nishimukai; Keiko Murase; Yuichi Takatsuka; Yasuo Miyoshi
International journal of clinical oncology, Dec. 2024 - Baseline neutrophil-to-lymphocyte ratio and c-reactive protein predict efficacy of treatment with bevacizumab plus paclitaxel for locally advanced or metastatic breast cancer.
Yoshimasa Miyagawa; Ayako Yanai; Takehiro Yanagawa; Junichi Inatome; Chiyomi Egawa; Arisa Nishimukai; Kaori Takamoto; Takashi Morimoto; Yuichiro Kikawa; Hirofumi Suwa; Tomoe Taji; Ai Yamaguchi; Yuki Okada; Atsushi Sata; Reiko Fukui; Ayako Bun; Hiromi Ozawa; Tomoko Higuchi; Yukie Fujimoto; Michiko Imamura; Yasuo Miyoshi
Oncotarget, Jan. 2020 - Significant Association Between Low Baseline Neutrophil-to-Lymphocyte Ratio and Improved Progression-free Survival of Patients With Locally Advanced or Metastatic Breast Cancer Treated With Eribulin But Not With Nab-Paclitaxel.
Yoshimasa Miyagawa; Kazuhiro Araki; Ayako Bun; Hiromi Ozawa; Yukie Fujimoto; Tomoko Higuchi; Arisa Nishimukai; Ayako Kira; Michiko Imamura; Yuichi Takatsuka; Yasuo Miyoshi
Clinical breast cancer, Oct. 2018 - High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
Yukie Fujimoto; Tomoko Higuchi; Arisa Nishimukai; Yoshimasa Miyagawa; Ayako Kira; Hiromi Ozawa; Ayako Bun; Michiko Imamura; Yasuo Miyoshi
Journal of surgical oncology, Jul. 2018 - Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Michiko Imamura; Takashi Morimoto; Takashi Nomura; Shintaro Michishita; Arisa Nishimukai; Tomoko Higuchi; Yukie Fujimoto; Yoshimasa Miyagawa; Ayako Kira; Keiko Murase; Kazuhiro Araki; Yuichi Takatsuka; Koshi Oh; Yoshikazu Masai; Kouhei Akazawa; Yasuo Miyoshi
World journal of surgical oncology, Feb. 2018 - Different patterns of change in bone turnover markers during treatment with bone-modifying agents for breast cancer patients with bone metastases.
Arisa Nishimukai; Tomoko Higuchi; Hiromi Ozawa; Ayako Yanai; Yoshimasa Miyagawa; Keiko Murase; Michiko Imamura; Yuichi Takatsuka; Yasuo Miyoshi
Breast cancer (Tokyo, Japan), Mar. 2017 - Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
Arisa Nishimukai; Natsuko Inoue; Ayako Kira; Masashi Takeda; Koji Morimoto; Kazuhiro Araki; Kazuhiro Kitajima; Takahiro Watanabe; Seiichi Hirota; Toyomasa Katagiri; Shoji Nakamori; Kouhei Akazawa; Yasuo Miyoshi
PloS one, 2017 - Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes.
Tomoko Higuchi; Arisa Nishimukai; Hiromi Ozawa; Yukie Fujimoto; Ayako Yanai; Yoshimasa Miyagawa; Keiko Murase; Michiko Imamura; Yuichi Takatsuka; Kazuhiro Kitajima; Kazuhito Fukushima; Yasuo Miyoshi
Breast (Edinburgh, Scotland), Dec. 2016 - Impact of biomarker changes during neoadjuvant chemotherapy for clinical response in patients with residual breast cancers.
Yukie Enomoto; Takashi Morimoto; Arisa Nishimukai; Tomoko Higuchi; Ayako Yanai; Yoshimasa Miyagawa; Keiko Murase; Michiko Imamura; Yuichi Takatsuka; Takashi Nomura; Masashi Takeda; Takahiro Watanabe; Seiichi Hirota; Yasuo Miyoshi
International journal of clinical oncology, Apr. 2016 - Prognostic significance of geminin expression levels in Ki67-high subset of estrogen receptor-positive and HER2-negative breast cancers.
Tomoko Yagi; Natsuko Inoue; Ayako Yanai; Keiko Murase; Michiko Imamura; Yoshimasa Miyagawa; Yukie Enomoto; Arisa Nishimukai; Yuichi Takatsuka; Seiichi Hirota; Kouhei Akazawa; Yasuo Miyoshi
Breast cancer (Tokyo, Japan), Mar. 2016 - High levels at baseline of serum pyridinoline crosslinked carboxyterminal telopeptide of type I collagen are associated with worse prognosis for breast cancer patients.
Michiko Imamura; Arisa Nishimukai; Tomoko Higuchi; Hiromi Ozawa; Ayako Yanai; Yoshimasa Miyagawa; Keiko Murase; Isao Sakita; Takuya Hatada; Yuichi Takatsuka; Toyomasa Katagiri; Yasuo Miyoshi
Breast cancer research and treatment, Dec. 2015 - Association between ¹⁸F-FDG uptake and molecular subtype of breast cancer.
Kazuhiro Kitajima; Kazuhito Fukushima; Yasuo Miyoshi; Arisa Nishimukai; Seiichi Hirota; Yoko Igarashi; Takayuki Katsuura; Kaoru Maruyama; Shozo Hirota
European journal of nuclear medicine and molecular imaging, Aug. 2015 - High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer.
Arisa Nishimukai; Tomoko Yagi; Ayako Yanai; Yoshimasa Miyagawa; Yukie Enomoto; Keiko Murase; Michiko Imamura; Yuichi Takatsuka; Isao Sakita; Takuya Hatada; Yasuo Miyoshi
Clinical breast cancer, Jun. 2015 - Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER(+), and HER2(-) Breast Cancer.
Ayako Yanai; Natsuko Inoue; Tomoko Yagi; Arisa Nishimukai; Yoshimasa Miyagawa; Keiko Murase; Michiko Imamura; Yukie Enomoto; Yuichi Takatsuka; Takahiro Watanabe; Seiichi Hirota; Mitsunori Sasa; Toyomasa Katagiri; Yasuo Miyoshi
Clinical breast cancer, Jun. 2015 - HER2陽性乳がん薬物治療 : 治療を完遂するための工夫(1)耐性機序を考慮した抗HER2薬の選択
西向 有沙; 三好 康雄
臨床腫瘍プラクティス = The practice of medical oncology, 2013 - Two giant renal aneurysms and renal arteriovenous fistula associated with cardiac insufficiency and a sustained elevation of atrial natriuretic peptide and brain natriuretic peptide.
Tsuyoshi Sakoda; Arisa Nishimukai; Takeshi Tsujino; Tohru Masuyama; Yuji Miyamoto; Mitsumasa Oyanagi
The American journal of the medical sciences, May 2007
